1. P690 Comparative efficacy of vedolizumab and adalimumab as second-line therapy in ulcerative colitis patients previously treated with infliximab. (25th January 2019) Authors: Favale, A; Onali, S; Caprioli, F; Pugliese, D; Armuzzi, A; Macaluso, F S; Orlando, A; Viola, A; Fries, W; Mocci, G; Chicco, F; Usai, P; Rispo, A; Castiglione, F; Calabrese, E; Biancone, L; Monteleone, G; Fantini, M C Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗